Authors: Laude, I Rongieres-Bertrand, C Boyer-Neumann, C Wolf, M Mairovitz, V Hugel, B Freyssinet, JM Frydman, R Meyer, D Eschwege, V

Citation: I. Laude et al., Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight, THROMB HAEM, 85(1), 2001, pp. 18-21

Authors: Wolf, M Boyer-Neumann, C Parent, F Eschwege, V Jaillet, H Meyer, D Simonneau, G

Citation: M. Wolf et al., Thrombotic risk factors in pulmonary hypertension, EUR RESP J, 15(2), 2000, pp. 395-399

Authors: Becquemont, L Camus, M Eschwege, V Barbu, V Rey, E Funck-Brentano, C Jaillon, P

Citation: L. Becquemont et al., Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man, FUN CL PHAR, 14(5), 2000, pp. 519-525

Authors: Robert, A Aillaud, MF Eschwege, V Randrianjohany, A Scarabin, Y Juhan-Vague, I

Citation: A. Robert et al., ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V leiden, THROMB HAEM, 83(4), 2000, pp. 630-631

Authors: Robert, A Aillaud, MF Eschwege, V Verdy, E Barthet, MC Morange, PE Juhan-Vague, I

Citation: A. Robert et al., Screening for identified and unidentified protein C pathway defects by theAgkistrodon contortrix venom test in consecutive patients, AM J CLIN P, 112(2), 1999, pp. 233-237